Black Diamond Therapeutics, Inc.
BDTX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $117,761 | $123,511 | $65,214 | $192,887 |
| - Cash | $36,437 | $56,221 | $34,315 | $65,799 |
| + Debt | $22,186 | $25,298 | $28,140 | $28,460 |
| Enterprise Value | $103,510 | $92,588 | $59,039 | $155,548 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$437 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$78,438 | -$86,023 | -$92,320 | -$126,667 |
| % Margin | – | – | – | – |
| Net Income | -$69,676 | -$82,442 | -$91,169 | -$125,596 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.27 | -1.88 | -2.52 | -3.47 |
| % Growth | 32.4% | 25.4% | 27.4% | – |
| Operating Cash Flow | -$62,303 | -$66,717 | -$85,082 | -$100,148 |
| Capital Expenditures | $0 | -$33 | -$192 | -$2,710 |
| Free Cash Flow | -$62,303 | -$66,750 | -$85,274 | -$102,858 |